“In the end, time is important – the worst that can happen is delays. What you really want is clear communication – even if things don’t go as they should. I get feedback from the project manager here all the time.” Anders Löfgren Chairman of the board since 2008. D.D.S, MBA. Managing Director of Nordic Drugs AB, 18 years experience with pharmaceutical marketing in different companies, the last 11 with Nordic Drugs. Conny Bogentoft Member of the board since 2008. Ph.D. in Medicinal Chemistry, Associate Professor in Pharmaceutical Chemistry. CEO at Karolinska Development. Has more than 30 years' experience of pharmaceutical industry, at senior R&D management positions and as a member of board of directors for a number of companies. Karl Olof Borg Member of the board since 2001. Ph.D. in Pharmaceutical Sciences. Chairman of the board of Bioinvent AB and Pharmexa A/S. Member of the board of Bioinvent International AB, 7 TM Pharma A/S, T-Cellic A/S, Medicon A/S and Eurocine AB. Jonas Edelswärd Member of the board since 2001. Degree in business. CEO of AB Axel Granlund and Pamtrima Aviation AB. Board member of Kotten Förvaltnings AB. Experience in business development and financing in high-tech companies. Has owned and run two companies. Former CEO of Teknopol. Henri Hansson Member of the board since 1999. M. Sc. Pharm, Director R & D and one of the founders of the company. Over the past 15 years, Henri has held different positions in the pharmaceutical industry. Ronnie Wallin Member of the board since 1999. M. Sc. Pharm, Managing Director and one of the founders of the company. Over the past 15 years, Ronnie has held different positions in the pharmaceutical industry.